Open-label trial

• Clinical research (13)

  • Blind experiment
  • Clinical trials
  • Clinical trial
  • Academic clinical trials
  • Placebo-controlled trial
  • Placebo-controlled trial
  • Multicenter trial
  • Clinical trial protocol
  • Randomized trial
  • First-in-man study
  • Placebo
  • Crossover trial
  • Inclusion criteria
  • Data monitoring committees
  • more...

• Medical statistics

  • Subgroup analysis
  • Study design
  • Clinical trial
  • First-in-man study

• Experimental design

  • Treatment groups
  • Blind experiment
  • Clinical trial
  • Placebo-controlled trial
  • Randomized trial
  • First-in-man study
  • Study design

• Scientific method

  • Pilot study
  • Blind experiment
  • Study design

• Medical research

  • Investigational new drug
  • Subgroup analysis

• Pharmacology (10)

  • Monotherapy
  • Dirucotide
  • Pharmacokinetic
  • FOLFOX
  • Blind experiment
  • Blind experiment
  • Clinical trial
  • Placebo-controlled trial
  • Randomized trial
  • Placebo
  • Crossover trial
  • more...

• Medicine

  • Point prevalence
  • Dose-ranging
  • Period prevalence
  • First-in-man study
  • Inclusion criteria

• Epidemiology

  • Attributable risk
  • Intent-to-treat
  • Clinical trials
  • Clinical trial
  • Randomized trial
  • Point prevalence
  • Period prevalence

• Clinical trial

  • Phase I trial
  • Phase II trial
  • Phase III
  • Clinical trial (Phases)

• Non-nucleoside reverse transcriptase inhibitors

  • Efavirenz
  • Nevirapine
  • TMC125
  • Atevirdine
  • Delavirdine
  • Emivirine
  • Rilpivirine

• Microtubule inhibitors

  • Docetaxel
  • Paclitaxel
  • Colchicine
  • Nocodazole
  • Taxane
  • Vinblastine

• Antineoplastic drugs (130)

  • Bevacizumab
  • Carboplatin
  • Cetuximab
  • Cyclophosphamide
  • Erlotinib
  • Erlotinib
  • Irinotecan
  • Oxaliplatin
  • Panitumumab
  • Temozolomide
  • ZD1839
  • Aclarubicin
  • Actinomycin
  • Alemtuzumab
  • Alitretinoin
  • Altretamine
  • Aminolevulinic acid
  • Amsacrine
  • Anagrelide
  • Antiestrogen
  • Arsenic trioxide
  • Asparaginase
  • Azacitidine
  • Bexarotene
  • Bleomycin
  • Bortezomib
  • Bropirimine
  • Busulfan
  • Capecitabine
  • Carboquone
  • Carmofur
  • Carmustine
  • Catumaxomab
  • Celecoxib
  • Chlorambucil
  • Cisplatin
  • Cladribine
  • Clofarabine
  • Cytarabine
  • Dacarbazine
  • Dasatinib
  • Daunorubicin
  • Decitabine
  • Demecolcine
  • Denileukin diftitox
  • Docetaxel
  • Doxorubicin
  • Edrecolomab
  • Efaproxiral
  • Epirubicin
  • Estramustine
  • Etoglucid
  • Etoposide
  • Everolimus
  • Fludarabine
  • Fluorouracil
  • Fotemustine
  • Fulvestrant
  • Gemcitabine
  • Gemtuzumab ozogamicin
  • Hydroxyurea
  • Idarubicin
  • Ifosfamide
  • Imatinib
  • Ixabepilone
  • Lapatinib
  • Lomustine
  • Lonidamine
  • Mannosulfan
  • Masoprocol
  • Mechlorethamine
  • Melphalan
  • Mercaptopurine
  • Methotrexate
  • Methyl aminolevulinate
  • Miltefosine
  • Mitobronitol
  • Mitoguazone
  • Mitomycin
  • Mitotane
  • Mitoxantrone
  • Monomethyl auristatin E
  • Nafoxidine
  • Nelarabine
  • Nilotinib
  • Nimustine
  • Oblimersen
  • Paclitaxel
  • Pazopanib
  • Pegaspargase
  • Pemetrexed
  • Pentostatin
  • Personalized medicine
  • Picoplatin
  • Pipobroman
  • Pirarubicin
  • Plicamycin
  • Porfimer sodium
  • Prednimustine
  • Procarbazine
  • Raltitrexed
  • Reditux
  • Rituximab
  • Satraplatin
  • Semustine
  • Sorafenib
  • Sparsomycin
  • Streptozotocin
  • Sunitinib
  • Tegafur
  • Temoporfin
  • Temsirolimus
  • Teniposide
  • ThioTEPA
  • Tiazofurin
  • Tioguanine
  • Toceranib
  • Topotecan
  • Trabectedin
  • Trastuzumab
  • Treosulfan
  • Tretinoin
  • Triaziquone
  • Trofosfamide
  • Valrubicin
  • Vinblastine
  • Vincristine
  • Vindesine
  • Vinorelbine
  • Vorinostat
  • Zorubicin
  • more...

• World Health Organization essential medicines (8)

  • Emtricitabine
  • 3TC
  • Ribavirin
  • Ritonavir
  • Lopinavir
  • Lopinavir
  • Nevirapine
  • Nelfinavir
  • Efavirenz
  • more...

• Types of cancer

  • Hormone-refractory prostate cancer
  • NSCLC
  • Ovarian carcinoma
  • Mycosis fungoides

• Monoclonal antibodies

  • Infliximab
  • Etanercept
  • Adalimumab
  • Bevacizumab
  • Panitumumab
  • Cetuximab

• TNF-alpha inhibitors

  • Adalimumab
  • Certolizumab pegol
  • Etanercept
  • Golimumab
  • Infliximab
  • TNF inhibitor

• Immunosuppressants (33)

  • Mycophenolate mofetil
  • Abatacept
  • Abetimus
  • Adalimumab
  • Afelimomab
  • Afelimomab
  • Alefacept
  • Anakinra
  • Anti-thymocyte globulin
  • Azathioprine
  • Basiliximab
  • Certolizumab pegol
  • Ciclosporin
  • Daclizumab
  • Eculizumab
  • Efalizumab
  • Etanercept
  • Everolimus
  • Gusperimus
  • Infliximab
  • Leflunomide
  • Lenalidomide
  • Mepolizumab
  • Methotrexate
  • Muromonab-CD3
  • Mycophenolic acid
  • Natalizumab
  • ReciGen
  • Rilonacept
  • Sirolimus
  • Tacrolimus
  • Thalidomide
  • Tocilizumab
  • Ustekinumab
  • more...

• Oncology

  • RECIST
  • HDAC inhibitor
  • Metastatic
  • Retrospective cohort study
  • MDV3100

• Diseases and disorders

  • Acute mania
  • Non-small cell lung cancer
  • Peripheral t-cell lymphoma
  • Hormone-refractory prostate cancer
  • NSCLC
  • Major depressive disorder
  • Ovarian carcinoma

• See also (20)

  • Analysis of clinical trials
  • Randomized
  • Public trial
  • Association (statistics)
  • Double blind
  • Double blind
  • Immunosuppressant drug
  • Animal testing on non-human primates
  • Seeding trial
  • J Altern Complement Med
  • Progression Free Survival
  • Ritonavir
  • Albuferon
  • Clinical Global Impression
  • Lopinavir
  • Bipolar I Disorder
  • Patients
  • Drotrecogin alfa (activated)
  • Levetiracetam
  • Remitting
  • Tibotec
  • more...

more categories...